Targeting tumor immunity with transferrin receptor-directed photodynamic therapy

Post author:
Post published:September 26, 2024
Post category:uncategorized

This new article publication from Acta Pharmaceutica Sinica B, discusses a transferrin receptor-targeted immunostimulant for photodynamic immunotherapy against metastatic tumors through β-catenin/CREB interruption.

Empowering individuals with knowledge, fostering healthier lifestyles, and fostering a community dedicated to diabetes awareness and prevention. Together, we’re shaping a healthier future.

Helpful Links

Subscribe To Us

By submitting via this part of the website you are granting us permission to store and process your data according to our Standard privacy policy

UPCOMING EVENTS

You Might Also Like

Hormonal contraceptives taken by adolescents may affect risk assessment behavior

Louisiana reclassifies drugs used in abortions as controlled dangerous substances

Study: 100% adoption of plant-based diets could save the NHS £6.7 billion a year

Helpful Links

Subscribe To Us